# EDGAR Filing Document

**Accession Number:** 0000785786
**File Stem:** 0000785786-25-000057
**Filing Date:** 2025-10
**Character Count:** 46863
**Document Hash:** 528cdf87d685b78fdcf406234de88b78
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000785786-25-000057.hdr.sgml**: 20251022

**ACCESSION NUMBER**: 0000785786-25-000057

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20251022

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251022

**DATE AS OF CHANGE**: 20251022

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PLEXUS CORP
- **CENTRAL INDEX KEY:** 0000785786
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 391344447
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 0927

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14423
- **FILM NUMBER:** 251410412

**BUSINESS ADDRESS:**
- **STREET 1:** PLEXUS CORP
- **STREET 2:** ONE PLEXUS WAY
- **CITY:** NEENAH
- **STATE:** WI
- **ZIP:** 54956
- **BUSINESS PHONE:** 9209696000

**MAIL ADDRESS:**
- **STREET 1:** PLEXUS CORP
- **STREET 2:** ONE PLEXUS WAY
- **CITY:** NEENAH
- **STATE:** WI
- **ZIP:** 54956

?xml version='1.0' encoding='ASCII'? plxs-20251022

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**____________________________________________________________________________________________________________________________________**

FORM 8-K

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**____________________________________________________________________________________________________________________________________**

Date of Report (Date of earliest event reported): October 22, 2025

**____________________________________________________________________________________________________________________________________**

![plxslogo8ka05.gif](plxs-20251022_g1.gif)

**PLEXUS CORP.** 

(Exact name of registrant as specified in its charter)

**____________________________________________________________________________________________________________________________________**

---

| | | |
|:---|:---|:---|
| **Wisconsin** | **001-14423** | **39-1344447** |
| (State or other jurisdiction<br> of incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**One Plexus Way** 

**Neenah, Wisconsin 54957** 

(Address of principal executive offices) (Zip Code)

**Telephone Number (920) 969-6000** 

(Registrant's telephone number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, $0.01 par value | PLXS | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;☐

------

**Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On October 22, 2025, Plexus Corp. ("we" or the "Company") announced results for the fiscal fourth quarter and year ended September 27, 2025. A copy of the Company's related press release is furnished as Exhibit 99.1 to this report.

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

(d) The following exhibits are filed herewith:

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | <u>[Press release issued by Plexus Corp., dated October 22, 2025](plxsf25q4earningsrelease-e.htm)</u> |
| 104 | Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document) |

---

------

**\* \* \* \* \***

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Date: October 22, 2025 | PLEXUS CORP. |
|  | (Registrant) |
|  | By: <u>/s/ Patrick J. Jermain</u> |
|  | Patrick J. Jermain |
|  | Executive Vice President and Chief Financial Officer |

---

## Exhibit 99.1

![plexusprlogo_1.gif](plexusprlogo_1.gif)

**Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results**

NEENAH, WI – October 22, 2025 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended September 27, 2025, and guidance for our fiscal first quarter ending January 3, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal fourth quarter revenue of $1.058 billion, GAAP operating margin of 5.0% and GAAP diluted EPS of $1.87.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal 2025 revenue of $4.033 billion, GAAP operating margin of 5.0% and GAAP diluted EPS of $6.26.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal fourth quarter non-GAAP operating margin of 5.8% and non-GAAP diluted EPS of $2.14, excluding $0.27 of stock-based compensation expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal 2025 non-GAAP operating margin of 5.9% and non-GAAP diluted EPS of $7.43, excluding $1.02 of stock-based compensation expense and $0.15 of restructuring and other charges.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Initiates fiscal first quarter 2026 revenue guidance of $1.050 billion to $1.090 billion with GAAP diluted EPS of $1.40 to $1.55, including $0.26 of stock-based compensation expense. Fiscal first quarter non-GAAP EPS guidance of $1.66 to $1.81 excludes stock-based compensation expense.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | Three Months Ended | Three Months Ended | Three Months Ended |
| | | Sep 27, 2025<br>Q4F25 Results | Sep 27, 2025<br>Q4F25 Guidance  | Jan 3, 2026<br>Q1F26 Guidance |
| **Summary GAAP Items** | **Summary GAAP Items** |  |  |  |
| Revenue (in billions) | Revenue (in billions) | $1.058 | $1.025 to $1.065 | $1.050 to $1.090 |
| Operating margin | Operating margin | 5.0% | 5.0% to 5.4% | 4.9% to 5.3% |
| Diluted EPS | Diluted EPS | $1.87 | $1.57 to $1.72 | $1.40 to $1.55 |
| **Summary Non-GAAP Items (1)** | **Summary Non-GAAP Items (1)** |  |  |  |
| Adjusted operating margin (2) | Adjusted operating margin (2) | 5.8% | 5.7% to 6.1% | 5.6% to 6.0% |
| Adjusted EPS (3) | Adjusted EPS (3) | $2.14 | $1.82 to $1.97 | $1.66 to $1.81 |
| Return on invested capital (ROIC) | Return on invested capital (ROIC) | 14.6% |  |  |
| Economic return | Economic return | 5.7% |  |  |
| *(1)* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* |
| *(2)* | *Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance.* | *Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance.* | *Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance.* | *Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance.* |
| *(3)* | *Excludes stock-based compensation expense, net of tax, of $0.27 for Q4F25 results, $0.25 for Q4F25 guidance and $0.26 for Q1F26 guidance.*  | *Excludes stock-based compensation expense, net of tax, of $0.27 for Q4F25 results, $0.25 for Q4F25 guidance and $0.26 for Q1F26 guidance.*  | *Excludes stock-based compensation expense, net of tax, of $0.27 for Q4F25 results, $0.25 for Q4F25 guidance and $0.26 for Q1F26 guidance.*  | *Excludes stock-based compensation expense, net of tax, of $0.27 for Q4F25 results, $0.25 for Q4F25 guidance and $0.26 for Q1F26 guidance.*  |

---

**Fiscal Fourth Quarter 2025 Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Won 28 manufacturing programs representing $274 million in annualized revenue when fully ramped into production.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Generated free cash flow of $97 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Purchased $21.5 million of our shares at an average price of $134.07 per share under our share repurchase programs. Under our current $100.0 million repurchase authorization, $85.0 million remains available.

------

**Fiscal Year 2025 Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Generated free cash flow of $154 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Produced ROIC of 14.6%, representing an economic return of 570 basis points above our weighted average cost of capital of 8.9%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Purchased $65.0 million of our shares at an average price of $136.80 per share.

*Todd Kelsey, President and Chief Executive Officer, commented, "The Plexus team continues to deliver a differentiated value proposition for our customers, and generated strong fiscal fourth quarter results. I am particularly pleased with our non-GAAP EPS of $2.14, which exceeded guidance, and our free cash flow, which again exceeded projections."*

*Mr. Kelsey continued, "Our go-to-market team generated 28 fiscal fourth quarter manufacturing wins, representing $274 million in annualized revenue. For fiscal 2025, the team generated 141 manufacturing wins representing $941 million in annualized revenue, which supports revenue growth exceeding that of our end markets. In addition, efforts to diversify our engineering solutions engagements successfully drove increased wins for fiscal 2025, while our sustaining services team achieved record wins for the fiscal year."*

*Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, "For the seventh consecutive quarter, our team drove a reduction in our gross inventory balance, ending the fiscal year $82 million lower than fiscal 2024. Fiscal fourth quarter cash cycle of 63 days was favorable to our expectations and sequentially lower by 6 days as we benefited from increased revenue and continued progress on our working capital initiatives. This level of cash cycle was the best result delivered in the past five years. Our favorable cash cycle combined with our strong operating performance produced fiscal 2025 return on invested capital of 14.6%, which exceeded our cost of capital by 570 basis points."*

*Mr. Jermain continued, "We delivered $154 million in free cash flow for fiscal 2025, a result well above our projections. Utilizing our exceptional free cash flow, we continued to execute upon our expanded share repurchase program and reduce our borrowing, ending the year in a net cash position. Finally, while we expect increased investments in support of future revenue growth and operational efficiency initiatives, we anticipate delivering robust fiscal 2026 free cash flow of approximately $100 million and deploying excess cash to create additional shareholder value."*

*Mr. Kelsey added, "We remain dedicated to our Plexus Value of Innovating Responsibly to help create the products that build a better world. For fiscal 2025, our global team contributed more than 32,000 paid volunteer hours to our local communities, a 47% year-over-year increase, Plexus donated $1.4 million to global non-profits through our Plexus Community Foundation and our team reduced waste to landfill by more than 30% globally, with eight Plexus sites now operating at zero waste to landfill. In addition, we reduced our absolute Scope 1 and 2 emissions by more than 10% across our global manufacturing sites versus our fiscal 2023 baseline."*

*Mr. Kelsey continued, "We are guiding fiscal first quarter revenue of $1.050 to $1.090 billion, non-GAAP operating margin of 5.6% to 6.0% and non-GAAP EPS of $1.66 to $1.81. New program ramps, inclusive of share gains, continue to drive our revenue growth in excess of modest end-market growth. In addition, during the fiscal first quarter, we will continue to invest in talent, technology, facilities and advanced capabilities to expand our industry-leading solutions, drive greater long-term operational efficiency and prepare for expected fiscal 2026 revenue growth."* 

------

*Mr. Kelsey concluded, "Fiscal 2025 was an outstanding year for Plexus. Our team delivered excellent operational execution, strong financial performance, including 40 basis points of non-GAAP operating margin expansion and 30% non-GAAP EPS growth, and robust and well-balanced new program wins across our solutions. These results provide momentum and position us well in fiscal 2026 to accelerate revenue growth toward our 9% to 12% goal and sustain strong financial performance."* 

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Quarterly & Annual Comparison** | Three Months Ended | Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended |
| *(in thousands, except EPS)* | Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 27, 2025 | Sep 28, 2024 |
| Revenue | $1058366 | $1018308 | $1050569 | $4032966 | $3960827 |
| Gross profit | 104783 | 103288 | 107912 | 406514 | 378530 |
| Operating income | 53112 | 53608 | 53858 | 202371 | 167732 |
| Net income | 51429 | 45116 | 41221 | 172885 | 111815 |
| Diluted EPS | $1.87 | $1.64 | $1.48 | $6.26 | $4.01 |
| Gross margin | 9.9% | 10.1% | 10.3% | 10.1% | 9.6% |
| Operating margin | 5.0% | 5.3% | 5.1% | 5.0% | 4.2% |
| ROIC (1) | 14.6% | 14.1% | 11.8% | 14.6% | 11.8% |
| Economic return (1) | 5.7% | 5.2% | 3.6% | 5.7% | 3.6% |
| *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* |

---

**Business Segment and Market Sector Revenue** 

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus' market sector focused strategy. Top 10 customers comprised 49% of revenue during the fourth quarter of fiscal 2025. This is up 1 percentage point from the third quarter of fiscal 2025 and down 3 percentage points from the fourth quarter of fiscal 2024. For fiscal 2025, top 10 customers comprised 49% of revenue, up 1 percentage point from fiscal 2024.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Business Segments ($ in millions)** | Three Months Ended | Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended |
|  | Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 27, 2025 | Sep 28, 2024 |
| Americas | $336 | $312 | $307 | $1217 | $1219 |
| Asia-Pacific | 605 | 594 | 618 | 2393 | 2213 |
| Europe, Middle East and Africa | 119 | 117 | 128 | 440 | 538 |
| Elimination of inter-segment sales | (2) | (5) | (2) | (17) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1058 | $1018 | $1051 | $4033 | $3961 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market Sectors ($ in millions)** | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended | Twelve Months Ended | Twelve Months Ended |
|  | Sep 27, 2025 | Sep 27, 2025 | Jun 28, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 28, 2024 | Sep 27, 2025 | Sep 27, 2025 | Sep 28, 2024 | Sep 28, 2024 |
| Aerospace/Defense | $173 | 16% | $183 | 18% | $184 | 18% | $689 | 17% | $698 | 19% |
| Healthcare/Life Sciences | 424 | 40% | 420 | 41% | 415 | 39% | 1629 | 40% | 1555 | 38% |
| Industrial | 461 | 44% | 415 | 41% | 452 | 43% | 1715 | 43% | 1708 | 43% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1058 |  | $1018 |  | $1051 |  | $4033 |  | $3961 |  |

---

------

**Non-GAAP Supplemental Information**

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

**ROIC and Economic Return**

ROIC for fiscal year 2025 was 14.6%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a five-quarter period for the fiscal year. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2025 was 8.9%. ROIC for fiscal year 2025 less Plexus' weighted average cost of capital resulted in an economic return of 5.7%.

**Free Cash Flow**

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended September 27, 2025, cash flows provided by operations was $132.0 million, less capital expenditures of $34.8 million, resulting in free cash flow of $97.2 million. For the fiscal year ended September 27, 2025, cash flows provided by operations was $249.2 million, less capital expenditures of $95.2 million, resulting in free cash flow of $154.0 million.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Cash Cycle Days** | **Cash Cycle Days** | Three Months Ended | Three Months Ended | Three Months Ended |
|  |  | Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 |
| Days in Accounts Receivable | Days in Accounts Receivable | 57 | 59 | 54 |
| Days in Contract Assets | Days in Contract Assets | 13 | 13 | 10 |
| Days in Inventory | Days in Inventory | 118 | 128 | 127 |
| Days in Accounts Payable | Days in Accounts Payable | (70) | (72) | (59) |
| Days in Advanced Payments | Days in Advanced Payments | (55) | (59) | (68) |
| &nbsp;&nbsp;&nbsp;&nbsp;Annualized Cash Cycle (1) | &nbsp;&nbsp;&nbsp;&nbsp;Annualized Cash Cycle (1) | 63 | 69 | 64 |
| *(1)* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* |

---

------

**Conference Call and Webcast Information**

---

| | |
|:---|:---|
| **What:**  | Plexus Fiscal Q4 and Fiscal Year 2025 Earnings Conference Call and Webcast |
| **When:**  | Thursday, October 23, 2025 at 8:30 a.m. Eastern Time |
| **Where:**  | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:<br>Webcast link:<br>https://events.q4inc.com/attendee/727582481 |
| **Replay:**  | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |

---

**Investor and Media Contact**

Shawn Harrison&nbsp;&nbsp;&nbsp;&nbsp;

+1.920.969.6325

shawn.harrison@plexus.com

**About Plexus**

Since 1979, Plexus has helped create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. For more information about Plexus, visit our website at www.plexus.com.

**Safe Harbor and Fair Disclosure Statement** 

*The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2024 Form 10-K.*

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
|  | Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended |
|  | Sep 27, | Sep 28, | Sep 27, | Sep 28, |
|  | 2025 | 2024 | 2025 | 2024 |
| Net sales | $1058366 | $1050569 | $4032966 | $3960827 |
| Cost of sales | 953583 | 942657 | 3626452 | 3582297 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 104783 | 107912 | 406514 | 378530 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and administrative expenses | 51671 | 54054 | 199460 | 190541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and other charges, net |  |  | 4683 | 20257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | 53112 | 53858 | 202371 | 167732 |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (2413) | (5577) | (11605) | (28876) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 883 | 1220 | 3922 | 3860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous, net | (1917) | (4087) | (6670) | (13184) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 49665 | 45414 | 188018 | 129532 |
| Income tax (benefit) expense | (1764) | 4193 | 15133 | 17717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $51429 | $41221 | $172885 | $111815 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.91 | $1.52 | $6.39 | $4.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.87 | $1.48 | $6.26 | $4.01 |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 26901 | 27203 | 27038 | 27397 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 27444 | 27783 | 27616 | 27909 |

---

------

---

| | | |
|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) |
|  | Sep 27, | Sep 28, |
|  | 2025 | 2024 |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $306464 | $345109 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 294 | 2353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 656573 | 622366 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 150654 | 120560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 1229839 | 1311434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 54969 | 75328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 2398793 | 2477150 |
| Property, plant and equipment, net | 546052 | 501112 |
| Operating lease right-of-use assets | 72863 | 74360 |
| Deferred income taxes | 91349 | 73919 |
| Other assets | 28053 | 27280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-current assets | 738317 | 676671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3137110 | $3153821 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt and finance lease obligations | $45793 | $157325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 726597 | 606378 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advanced payments from customers | 575850 | 709152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries and wages | 109076 | 94448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued liabilities | 61367 | 75991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1518683 | 1643294 |
| Long-term debt and finance lease obligations, net of current portion | 91987 | 89993 |
| Accrued income taxes payable |  | 17198 |
| Long-term operating lease liabilities | 29422 | 32275 |
| Deferred income taxes | 6000 | 8234 |
| Other liabilities | 36430 | 38002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-current liabilities | 163839 | 185702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1682522 | 1828996 |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 547 | 545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in-capital | 695653 | 680638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock held in treasury | (1255451) | (1190115) |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1996028 | 1823143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 17811 | 10614 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 1454588 | 1324825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $3137110 | $3153821 |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
|  |  | Three Months Ended | Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended |
|  |  | Sep 27, | Jun 28, | Sep 28, | Sep 27, | Sep 28, |
|  |  | 2025 | 2025 | 2024 | 2025 | 2024 |
| Operating income, as reported | Operating income, as reported | $53112 | $53608 | $53858 | $202371 | $167732 |
| Operating margin, as reported | Operating margin, as reported | 5.0% | 5.3% | 5.1% | 5.0% | 4.2% |
| Non-GAAP adjustments: | Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs (1) |  |  |  | 4683 | 22507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income (2) |  |  |  |  | (2250) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 7803 | 7691 | 10849 | 29616 | 30485 |
| Non-GAAP operating income | Non-GAAP operating income | $60915 | $61299 | $64707 | $236670 | $218474 |
| Non-GAAP operating margin | Non-GAAP operating margin | 5.8% | 6.0% | 6.2% | 5.9% | 5.5% |
| Net income, as reported | Net income, as reported | $51429 | $45116 | $41221 | $172885 | $111815 |
| Non-GAAP adjustments: | Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) |  |  |  | 4191 | 20144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) |  |  |  |  | (2014) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | 7414 | 7307 | 10306 | 28136 | 29582 |
| Adjusted net income | Adjusted net income | $58843 | $52423 | $51527 | $205212 | $159527 |
| Diluted earnings per share, as reported | Diluted earnings per share, as reported | $1.87 | $1.64 | $1.48 | $6.26 | $4.01 |
| Non-GAAP per share adjustments: | Non-GAAP per share adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) |  |  |  | 0.15 | 0.72 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) |  |  |  |  | (0.07) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | 0.27 | 0.26 | 0.37 | 1.02 | 1.06 |
| Adjusted diluted earnings per share | Adjusted diluted earnings per share | $2.14 | $1.90 | $1.85 | $7.43 | $5.72 |
| *(1)* | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  | *During the twelve months ended September 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions.*<br>*During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.*  |
| *(2)* | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  | *During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.*  |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** |
| (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
| **ROIC and Economic Return Calculations** | Twelve Months Ended | Twelve Months Ended | Nine Months Ended | Nine Months Ended | Twelve Months Ended | Twelve Months Ended |
|  | Sep 27, | Sep 27, | Jun 28, | Jun 28, | Sep 28, | Sep 28, |
|  | 2025 | 2025 | 2025 | 2025 | 2024 | 2024 |
| Operating income, as reported |  | $202371 |  | $149259 |  | $167732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and other charges, net |  | 4683 |  | 4683 |  | 20257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accelerated stock-based compensation (1) | + |  | + |  | + | 5063 |
| Adjusted operating income |  | $207054 |  | $153942 |  | $193052 |
|  |  |  | ÷ | 3 |  |  |
|  |  |  |  | $51314 |  |  |
|  |  |  | x | 4 |  |  |
| Adjusted annualized operating income |  | $207054 |  | $205256 |  | $193052 |
| Adjusted effective tax rate | x | 8% | x | 11% | x | 13% |
| Tax impact |  | 16564 |  | 22578 |  | 25097 |
| Adjusted operating income (tax-effected) |  | $190490 |  | $182678 |  | $167955 |
| Average invested capital | ÷ | $1303575 | ÷ | $1298575 | ÷ | $1418698 |
| ROIC |  | 14.6% |  | 14.1% |  | 11.8% |
| Weighted average cost of capital | - | 8.9% | - | 8.9% | - | 8.2% |
| Economic return |  | 5.7% |  | 5.2% |  | 3.6% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Average Invested Capital Calculations** | Sep 27, | Jun 28, | Mar 29, | Dec 28, | Sep 28, |
|  | 2025 | 2025 | 2025 | 2024 | 2024 |
| Equity | $1454588 | $1419085 | $1351675 | $1319069 | $1324825 |
| Plus: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - current | 45793 | 50678 | 121014 | 121977 | 157325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - current (2) | 8253 | 8470 | 9968 | 14875 | 14697 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - long-term | 91987 | 92215 | 88761 | 88728 | 89993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - long-term | 29422 | 31192 | 32720 | 35124 | 32275 |
| Less: Cash and cash equivalents | (306464) | (237567) | (310531) | (317161) | (345109) |
|  | $1323579 | $1364073 | $1293607 | $1262612 | $1274006 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Average Invested Capital Calculations** | Jun 29, | Mar 30, | Dec 30, | Sep 30, |
|  | 2024 | 2024 | 2023 | 2023 |
| Equity | $1266360 | $1259762 | $1266755 | $1214382 |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - current | 258175 | 245964 | 251119 | 240205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - current (2) | 7990 | 8281 | 9172 | 8363 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - long-term | 90715 | 192025 | 192118 | 190853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - long-term | 31923 | 33915 | 35989 | 38552 |
| Less: Cash and cash equivalents | (269868) | (265053) | (231982) | (256233) |
|  | $1385295 | $1474894 | $1523171 | $1436122 |

---

*(1)* *During the twelve months ended September 28, 2024, $5.1 million of accelerated stock-based compensation expense was recorded in selling and administrative expense in the accompanying Condensed Consolidated Statements of Operations as a result of a previously announced executive retirement agreement.*

*(2)* *Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.*